Novo Nordisk® logo
NovoCare® Savings | Coverage | Support NovoCare® Savings | Coverage | Support
Novo Nordisk® logo

Terms and Conditions of Use

NovoCare® Pharmacy (CoAssist Pharmacy d/b/a NovoCare® Pharmacy)

Covered products:

Wegovy® (semaglutide) injection 2.4 mg

Total strength per total volume
NDC

0.25 mg/0.5 mL
0169-4525-14

0.5 mg/0.5 mL
0169-4505-14

1 mg/0.5 mL
0169-4501-14 

1.7 mg/0.75 mL
0169-4517-14

2.4 mg/0.75 mL
0169-4524-14

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, 2 mg

Total strength per total volume
NDC

2 mg/3 mL
0169-4181-13

4 mg/3 mL
0169-4130-13

8 mg/3 mL
0169-4772-12

Eligibility and Restrictions

Ozempic®:

To participate in the Ozempic® NovoCare® Pharmacy program, patients must have a valid prescription for Ozempic®. A valid Prescriber ID# is required on the prescription. 

Patients are not eligible for the Ozempic® NovoCare® Pharmacy program if enrolled in any federal or state health care program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a government program), or where prohibited by law.

Patients may only participate in this NovoCare® program for Ozempic® if they have been prescribed Ozempic® for an FDA-approved indication within that product’s labeling.

Wegovy®:

In order to participate in the Wegovy® NovoCare® Pharmacy program, patient must have a valid prescription for Wegovy®. A valid Prescriber ID# is required on the prescription. 

Patients must either be uninsured or have insurance but decide to self-pay. Patients may only participate in this Wegovy® program if they have been prescribed Wegovy® for an FDA-approved indication with that product’s labeling.

Program Details for Ozempic®

By using this program, patient must certify that they meet the eligibility criteria and will comply with the terms and conditions described for Ozempic® Eligibility, Ozempic®’s Program Details, and Program Details applicable to either Ozempic® or Wegovy®. 

Patient agrees they will not seek reimbursement for any medication received through this program.

When a prescription for Ozempic® is received from a licensed prescriber, NovoCare® will review and validate the prescription. Patients will have the option to utilize the self-pay/cash program through CenterWell® and/or CoAssist Pharmacy d/b/a NovoCare® Pharmacy (“NovoCare® Pharmacy”), or for those who have commercial insurance, have NovoCare® Pharmacy transfer the prescription to a retail pharmacy to apply their commercial prescription insurance to the prescription fulfillment.

Patients enrolled in this program can pay:

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, 2 mg

Self-pay offer details

Total strength per volume

NDC

Price for 1 month (1 box)

Price for 2 month (2 boxes)

Price for 3 month (3 boxes)

Limited Time Offer for new patientsa: $199

Ozempic® 2 mg/3 mL

00169-4181-13

$349

$698

$1,047

Ozempic® 4 mg/3 mL

00169-4130-13

$349

$698

$1,047

Ozempic® 8 mg/3 mL

00169-4772-12

$499

$698

$1,047

Self-pay offer details
(effective November 17, 2025)

Total strength per volume
Ozempic® 2 mg/3 mL

NDC
00169-4181-13

Price for 1 month (1 box)
Limited Time Offer for new patientsa: $199
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Ozempic® 4 mg/3 mL

NDC
00169-4130-13

Price for 1 month (1 box)
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Ozempic® 8 mg/3 mL

NDC
00169-4772-12

Price for 1 month (1 box)
$499

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

aOzempic® injection 0.25 mg and 0.5 mg (2 mg/3 mL): For a limited time, patients who have not already filled a prescription for Ozempic® injection through NovoCare® Pharmacy will be eligible for a promotional offer of $199 for each monthly fill (1 box) of the Ozempic® 2 mg/3 ml injection. Offer only available for 2 monthly fills between November 17, 2025–March 31, 2026. For each fill after and for Ozempic® 4 mg/3 mL injection, you will pay $349 per 1-month prescription (1 box), $698 per 2-month prescription (2 boxes), or $1,047 per 3-month prescription (3 boxes) of Ozempic®. For Ozempic® 8 mg/3 mL, you will pay $499 per 1-month prescription (1 box), $998 per 2-month prescription (2 boxes), or $1,497 per 3-month prescription (3 boxes) of Ozempic®.

Patients are eligible for the limited-time offer so long as the prescription is received by NovoCare® Pharmacy by end of day on 3/31/2026 and shipped on or before 4/30/2026.

Program Details for Wegovy®

By using this program, patient must certify that they meet the eligibility criteria and will comply with the terms and conditions described for Wegovy® Eligibility, Wegovy®’s Program Details, and Program Details applicable to either Wegovy® or Ozempic®.

Patient also agrees that they will not seek reimbursement for any medication received through this program.

When a prescription for Wegovy® is received from a licensed prescriber, NovoCare® will review and validate the prescription. Patients will have the option to utilize the self-pay/cash program through CenterWell® and/or CoAssist Pharmacy d/b/a NovoCare® Pharmacy (“NovoCare® Pharmacy”).

Patients in this Wegovy® self-pay program who otherwise might participate in Medicare Part D or a Medicare Advantage prescription drug plan must agree to the following conditions for the Wegovy® self-pay/NovoCare® Pharmacy program:

  • The patient must agree not to seek reimbursement from their Medicare Part D or Medicare Advantage prescription plan for their out-of-pocket costs for their Wegovy® prescription or count the costs of their prescription toward their deductible or True out-of-pocket (“TrOOP”) costs. 
  • The patient must also agree to purchase all of their Wegovy® prescriptions through the program for the entire calendar year.
  • The patient must agree to permit Novo Nordisk to notify the patient’s Medicare Part D or Medicare Advantage prescription plan about their participation in the program.

Patients enrolled in this program can pay:

Wegovy® (semaglutide) injection 2.4mg:

Self-pay offer details

Total strength per volume

NDC

Price for 1 month (1 box)

Price for 2 month (2 boxes)

Price for 3 month (3 boxes)

Limited Time Offer for new patientsb: $199

Wegovy® 0.25 mg/0.5 mL injection

0169-4525-14

$349

$698

$1,047

Limited Time Offer for new patientsa: $199

Wegovy® 0.5 mg/0.5 mL injection

0169-4505-14

$349

$698

$1,047

Wegovy® 1 mg/0.5 mL injection

0169-4501-14 

$349

$698

$1,047

Wegovy® 1.7 mg/0.75 mL injection

0169-4517-14

$349

$698

$1,047

Wegovy® 2.4 mg/0.75 mL injection

0169-4524-14

$349

$698

$1,047

Self-pay offer details
(effective November 17, 2025)

Total strength per volume
Wegovy® 0.25 mg/0.5 mL injection

NDC
0169-4525-14

Price for 1 month (1 box)
Limited Time Offer for new patientsb: $199
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Wegovy® 0.5 mg/0.5 mL injection

NDC
0169-4505-14

Price for 1 month (1 box)
Limited Time Offer for new patientsa: $199
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Wegovy® 1 mg/0.5 mL injection

NDC
0169-4501-14 

Price for 1 month (1 box)
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Wegovy® 1.7 mg/0.75 mL injection

NDC
0169-4517-14

Price for 1 month (1 box)
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

Total strength per volume
Wegovy® 2.4 mg/0.75 mL injection

NDC
0169-4524-14

Price for 1 month (1 box)
$349

Price for 2 month (2 boxes)
$689

Price for 3 month (3 boxes)
$1,047

bWegovy® injection 0.25 mg and 0.5 mg: For a limited time, patients who have not already filled a prescription for Wegovy® injection through NovoCare® Pharmacy will be eligible for a promotional offer of $199 for each monthly fill (1 box) of the Wegovy® injection 0.25 mg and 0.5 mg strengths. Offer only available for 2 monthly fills between November 17, 2025–March 31, 2026. For each fill after and for other Wegovy® dose strengths, you will pay $349 per 1-month prescription (1 box), $698 per 2-month prescription (2 boxes), or $1,047 per 3-month prescription (3 boxes) of Wegovy®.

Patients are eligible for the limited-time offer so long as the prescription is received by NovoCare® Pharmacy by end of day on 3/31/2026 and shipped on or before 4/30/2026.

Program Details that Apply to Wegovy® or Ozempic®

NovoCare® Pharmacy operates through licensed pharmacies that dispense product under a cash-pay model, and insurance is not accepted. These cash prescriptions are filled by CenterWell® Pharmacy or CoAssist Pharmacy d/b/a Novocare® Pharmacy.

Patients enrolled in this program can pay $499 per 28-day supply (1 box), $998 per 56-day supply (2 boxes), or $1,497 per 84-day supply (3 boxes) of Wegovy® or Ozempic®, as submitted by the prescriber. Patients must provide payment prior to the dispensing and shipment of their prescription.

Novo Nordisk’s Eligibility and Restrictions, and Program Details, may change from time to time, and for the most recent version, please visit this webpage. Reconfirmation of patient information may be requested periodically to ensure accuracy of data and compliance with terms. Patients with questions about the program may call 1-888-809-3942.

This offer is not insurance. This offer is not contingent on any past, current, or future purchase of Ozempic® or Wegovy®. This offer cannot be combined with any other coupon, free trial, discount, prescription savings card, or other offer not associated with this offer. This offer is valid only in the United States and its territories, unless prohibited by law.

Assurance of Medication Supply

This program will continue to enroll patients so long as each enrolled patient can receive a consistent supply of medication. This assurance is only applicable for those patients who remain enrolled and adherent to the treatment. Novo Nordisk reserves the right to pause or terminate enrollment to prioritize supply for those qualified.

Disclosure of Third-Party Partnerships

AssistRx: A patient solutions provider responsible for NovoCare®’s access and reimbursement live support program. They manage patient intake and outreach and offer live support. 

CoAssist: A licensed pharmacy in all 50 US States and territories that for purposes of this program is CoAssist Pharmacy d/b/a NovoCare® Pharmacy. CoAssist takes in the prescription after NovoCare®’s access and reimbursement live support program reviews patient’s insurance type and benefits investigation to determine eligibility for program. Eligible patients may then have their HCP’s prescription transferred from CoAssist to CenterWell® Pharmacy, where CenterWell® further validates the prescription, and processes it for shipment to patient’s home or CoAssist Pharmacy d/b/a NovoCare® Pharmacy may act as the dispensing pharmacy.

CenterWell®: NovoCare®’s dispensing pharmacy responsible for patient accounts, payment collection, medication fulfillment, tracking, and shipping.

NovoCare_Ozempic_v01

Important Safety Information for Ozempic®

Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.

What is the most important information I should know about Ozempic®?

Ozempic® may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your health care provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Ozempic® and medicines that work like Ozempic® caused thyroid tumors, including thyroid cancer. It is not known if Ozempic® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people.
  • Do not use Ozempic® if you or any of your family have ever had MTC, or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

What is Ozempic®?

Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is an injectable prescription medicine used:

  • along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.
  • to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease.
  • to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease.

It is not known if Ozempic® is safe and effective for use in children.

Important Safety Information

Do not use Ozempic® if:

  • you or any of your family have ever had MTC or if you have MEN 2.
  • you are allergic to semaglutide or any of the ingredients in Ozempic®. See symptoms of serious allergic reaction in “What are the possible side effects of Ozempic®?”.

Before using Ozempic®, tell your health care provider if you have any other medical conditions, including if you:

  • have or have had problems with your pancreas.
  • have a history of diabetic retinopathy.
  • have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food.
  • are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation).
  • are pregnant or breastfeeding or plan to become pregnant or breastfeed. It is not known if Ozempic® will harm your unborn baby or pass into your breast milk. You should stop using Ozempic® at least 2 months before you plan to become pregnant.

Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.

What are the possible side effects of Ozempic®?

Ozempic® may cause serious side effects, including:

  • inflammation of your pancreas (pancreatitis). Stop using Ozempic® and call your health care provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
  • changes in vision. Tell your health care provider if you have changes in vision during treatment with Ozempic®.
  • low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Ozempic® with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include: dizziness or lightheadedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery.
  • dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your health care provider right away if you have nausea, vomiting, or diarrhea that does not go away.
  • severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Ozempic®. Tell your health care provider if you have stomach problems that are severe or will not go away.
  • serious allergic reactions. Stop using Ozempic® and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
  • gallbladder problems. Gallbladder problems have happened in some people who take Ozempic®. Tell your healthcare provider right away if you get symptoms which may include: pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools.
  • food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Ozempic® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Ozempic® before you are scheduled to have surgery or other procedures.

The most common side effects of Ozempic® may include nausea, vomiting, diarrhea, stomach (abdominal) pain, and constipation.

Please see Prescribing Information and Medication Guide for Ozempic®.

Ozempic® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

 

NovoCare_Wegovy_v02

Important Safety Information for Wegovy®

What is the most important information I should know about Wegovy®?

Wegovy® may cause serious side effects, including:

  • Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
  • Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

What is Wegovy®?

Wegovy® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity:

  • to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
  • that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off.

Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.

It is not known if Wegovy® is safe and effective for use in children under 12 years of age.

Important Safety Information

Do not use Wegovy® if:

  • you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy®

Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:

  • have or have had problems with your pancreas or kidneys
  • have type 2 diabetes and a history of diabetic retinopathy
  • have or have had depression, suicidal thoughts, or mental health issues
  • are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)
  • are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant
  • are breastfeeding or plan to breastfeed. It is not known if Wegovy® passes into your breast milk

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.

What are the possible side effects of Wegovy®?

Wegovy® may cause serious side effects, including:

  • inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back
  • gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools
  • increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery
  • kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration
  • severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away
  • serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat
  • change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy®
  • increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes
  • depression or thoughts of suicide. You should pay attention to any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any mental changes that are new, worse, or worry you
  • food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures

The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and runny nose or sore throat.

Please see Prescribing Information and Medication Guide for Wegovy®.

Wegovy® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

 

Please see Prescribing Information and Medication Guide for Wegovy®.

Wegovy® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.